These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 19089566)

  • 1. Recurrence of polypoidal choroidal vasculopathy after photodynamic therapy.
    Yamashiro K; Tsujikawa A; Nishida A; Mandai M; Kurimoto Y
    Jpn J Ophthalmol; 2008; 52(6):457-462. PubMed ID: 19089566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term results of photodynamic therapy of polypoidal choroidal vasculopathy.
    Akaza E; Mori R; Yuzawa M
    Retina; 2008 May; 28(5):717-22. PubMed ID: 18463515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of intravitreal bevacizumab combined with photodynamic therapy for polypoidal choroidal vasculopathy.
    Gomi F; Sawa M; Wakabayashi T; Sasamoto Y; Suzuki M; Tsujikawa M
    Am J Ophthalmol; 2010 Jul; 150(1):48-54.e1. PubMed ID: 20609707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravitreal ranibizumab with or without photodynamic therapy for the treatment of symptomatic polypoidal choroidal vasculopathy.
    Lai TY; Lee GK; Luk FO; Lam DS
    Retina; 2011 Sep; 31(8):1581-8. PubMed ID: 21610566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors influencing visual outcome of polypoidal choroidal vasculopathy one year after photodynamic therapy.
    Mori R; Yuzawa M; Lee Z; Haruyama M; Akaza E
    Graefes Arch Clin Exp Ophthalmol; 2010 Sep; 248(9):1233-9. PubMed ID: 20352440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photodynamic therapy combined with intravitreal injection of vascular endothelial growth factor antibody for polypoidal choroidal vasculopathy.
    Moon SW; Kim MS; Kim ES; Yu SY; Kwak HW
    Ophthalmologica; 2011; 225(3):169-75. PubMed ID: 21273795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indocyanine green angiography: guided photodynamic therapy for polypoidal choroidal vasculopathy.
    Otani A; Sasahara M; Yodoi Y; Aikawa H; Tamura H; Tsujikawa A; Yoshimura N
    Am J Ophthalmol; 2007 Jul; 144(1):7-14. PubMed ID: 17467649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two-year results of photodynamic therapy for polypoidal choroidal vasculopathy.
    Kurashige Y; Otani A; Sasahara M; Yodoi Y; Tamura H; Tsujikawa A; Yoshimura N
    Am J Ophthalmol; 2008 Oct; 146(4):513-519. PubMed ID: 18614133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of polypoidal choroidal vasculopathy with photodynamic therapy combined with intravitreal injections of ranibizumab.
    Tomita K; Tsujikawa A; Yamashiro K; Ooto S; Tamura H; Otani A; Nakayama Y; Yoshimura N
    Am J Ophthalmol; 2012 Jan; 153(1):68-80.e1. PubMed ID: 21907965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravitreal ranibizumab for polypoidal choroidal vasculopathy with recurrent or residual exudation.
    Saito M; Iida T; Kano M
    Retina; 2011 Sep; 31(8):1589-97. PubMed ID: 21654347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemorrhagic complications after photodynamic therapy for polypoidal choroidal vasculopathy.
    Hirami Y; Tsujikawa A; Otani A; Yodoi Y; Aikawa H; Mandai M; Yoshimura N
    Retina; 2007 Mar; 27(3):335-41. PubMed ID: 17460589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One-year outcomes of photodynamic therapy in age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients.
    Gomi F; Ohji M; Sayanagi K; Sawa M; Sakaguchi H; Oshima Y; Ikuno Y; Tano Y
    Ophthalmology; 2008 Jan; 115(1):141-6. PubMed ID: 17582498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up of polypoidal choroidal vasculopathy after photodynamic therapy with verteporfin.
    Sayanagi K; Gomi F; Sawa M; Ohji M; Tano Y
    Graefes Arch Clin Exp Ophthalmol; 2007 Oct; 245(10):1569-71. PubMed ID: 17437122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features and follow-up results of pulsating polypoidal choroidal vasculopathy treated with photodynamic therapy.
    Byeon SH; Lew YJ; Lee SC; Kwon OW
    Acta Ophthalmol; 2010 Sep; 88(6):660-8. PubMed ID: 19563374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photodynamic therapy for polypoidal choroidal vasculopathy: vaso-occlusive effect on the branching vascular network and origin of recurrence.
    Lee WK; Lee PY; Lee SK
    Jpn J Ophthalmol; 2008; 52(2):108-115. PubMed ID: 18626733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-year follow-up results of photodynamic therapy for polypoidal choroidal vasculopathy.
    Akaza E; Yuzawa M; Mori R
    Jpn J Ophthalmol; 2011 Jan; 55(1):39-44. PubMed ID: 21331691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One-year results of intravitreal ranibizumab with or without photodynamic therapy for polypoidal choroidal vasculopathy.
    Song MH; Ryu HW; Roh YJ
    Ophthalmologica; 2011; 226(3):119-26. PubMed ID: 21757883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photodynamic therapy with verteporfin in polypoidal choroidal vasculopathy: results after 3 years of follow-up.
    Leal S; Silva R; Figueira J; Cachulo ML; Pires I; de Abreu JR; Cunha-Vaz JG
    Retina; 2010 Sep; 30(8):1197-205. PubMed ID: 20827139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photodynamic therapy for typical age-related macular degeneration and polypoidal choroidal vasculopathy: a 30-month multicenter study in Hyogo, Japan.
    Honda S; Kurimoto Y; Kagotani Y; Yamamoto H; Takagi H; Uenishi M;
    Jpn J Ophthalmol; 2009 Nov; 53(6):593-597. PubMed ID: 20020237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-year results of reduced-fluence photodynamic therapy for polypoidal choroidal vasculopathy.
    Yamashita A; Shiraga F; Shiragami C; Ono A; Tenkumo K
    Am J Ophthalmol; 2010 Mar; 149(3):465-71.e1. PubMed ID: 20042180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.